Evidence map›Paper›PMID 41735915›Full record

ArticleBMC infectious diseases2026

Pyogenic psoas abscess: clinical profiles, imaging features, and outcomes in a retrospective single-center study of 32 cases.

Bircan Kayaaslan, Zeynep Oktay, Aysuna Galandarova, Fatma Eser, İmran Hasanoğlu, Ayse Kaya, Tuğba Başçıoğlu, Rahmet Güner

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bircan KayaaslanDepartment of Infectious Disease and Clinical Microbiology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, Bilkent Street No:1, Ankara, 06800, Turkey. bkayaaslan@aybu.edu.tr.ORCID http://orcid.org/0000-0001-5225-8319
Zeynep OktayDepartment of Infectious Disease and Clinical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0001-7186-7670
Aysuna GalandarovaAnkara Bilkent City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.
Fatma EserDepartment of Infectious Disease and Clinical Microbiology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, Bilkent Street No:1, Ankara, 06800, Turkey.ORCID http://orcid.org/0000-0002-0282-6346
İmran HasanoğluDepartment of Infectious Disease and Clinical Microbiology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, Bilkent Street No:1, Ankara, 06800, Turkey.ORCID http://orcid.org/0000-0001-6692-3893
Ayse KayaDepartment of Infectious Disease and Clinical Microbiology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, Bilkent Street No:1, Ankara, 06800, Turkey.ORCID http://orcid.org/0000-0002-4759-0066
Tuğba BaşçıoğluDepartment of Infectious Disease and Clinical Microbiology, Ankara Bilkent City Hospital, Ankara, Turkey.
Rahmet GünerDepartment of Infectious Disease and Clinical Microbiology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, Bilkent Street No:1, Ankara, 06800, Turkey.ORCID http://orcid.org/0000-0002-1029-1185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPsoas abscess is a rare, complex condition often associated with various underlying diseases and nonspecific clinical signs, which can delay diagnosis and increase mortality. This study aimed to evaluate the clinical, epidemiological, and radiological characteristics, as well as treatment outcomes, of patients diagnosed with psoas abscess.

methodsThis retrospective study included patients with psoas abscess treated at Ankara Bilkent City Hospital between February 2019 and February 2022. Epidemiological data, comorbidities, microorganisms identified in abscess or blood cultures, imaging findings, and treatment outcomes were analyzed. Abscesses without an identifiable infectious source were classified as primary, while those secondary to nearby infections were classified as secondary. Statistical analysis was performed using SPSS 20.0.

resultsThirty-two patients were included: 9 with primary and 23 with secondary abscesses. The mean age was 60.5 ± 14.6 years, and 62.5% were male. Predisposing factors included prior surgery (31%), vertebral osteomyelitis (25%), trauma (12.5%), and foreign bodies (12.5%). Common symptoms were back pain (78.1%), radiating leg pain (50%), fever (53.1%), and chills (62.5%), with symptom duration exceeding 15 days in 46.9% of cases. Primary abscesses were often associated with immunosuppression (44.4%), whereas secondary abscesses most frequently involved musculoskeletal (82.6%) or cardiovascular systems (26%). Among pathogens isolated from abscess cultures, Staphylococcus aureus was the most frequently identified organism, followed by Streptococcus spp. and Enterococcus spp. Brucellosis and tuberculosis were identified in selected patients based on serological or immunological criteria. Half of the patients underwent percutaneous drainage plus antibiotics; others received either antibiotics alone (25%) or drainage with surgery (18%). The median duration of antibiotic therapy was 48 days. Complete cure was achieved in 46.9% of patients, 40.6% recovered with sequelae, and 12.5% died. Recurrence occurred in ten patients.

conclusionPsoas abscess remains a rare but serious condition with diverse etiologies. Prompt recognition and prolonged treatment are critical, and S. aureus is the most frequently isolated pathogen.

Indexed as

Psoas AbscessAdultAgedAnti-Bacterial AgentsFemaleHumansMaleMiddle AgedRetrospective StudiesStaphylococcal InfectionsTreatment OutcomeAnti-Bacterial AgentsPsoas abscessPyogenic abscessS. aureusSpinal infectionsSpondylodiscitis

Identifiers

PMID41735915
PMCPMC13041038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.